{"id":66350,"date":"2026-01-17T08:52:02","date_gmt":"2026-01-17T07:52:02","guid":{"rendered":"https:\/\/www.parkinson-hotline.com\/?p=66350"},"modified":"2026-02-03T04:23:04","modified_gmt":"2026-02-03T03:23:04","slug":"can-the-course-of-the-disease-be-slowed-down","status":"publish","type":"post","link":"https:\/\/www.parkinson-hotline.com\/en\/kann-man-den-verlauf-der-erkrankung-verlangsamen\/","title":{"rendered":"Can the progression of the disease be slowed down?"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Can the progression of the disease be slowed down?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t


Introduction<\/strong><\/p>

One of the most frequently asked questions by people with Parkinson's and their relatives is:\u201eCan the progression of the disease be slowed down?\u201c<\/strong><\/p>

There is currently no cure for Parkinson's disease. Nevertheless, medical findings show that certain therapeutic approaches can functional progression<\/strong> can have a positive influence on the disease.<\/p>

Here Targeted movement, motor learning and individually adapted training<\/strong> play a central role - as they are also used in specialized forms of therapy such as GIGER\u00ae MD\u00ae Therapy.<\/p>

\u00a0<\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

What does \u201eslow down progression\u201c actually mean?<\/strong><\/p>

When we talk about the progression of Parkinson's disease, we are not talking about stopping the disease itself, but about:<\/p>

  • maintaining mobility for as long as possible,<\/li>
  • the delay of functional limitations,<\/li>
  • more security and independence in everyday life.<\/li><\/ul>


    The course of the disease varies greatly from person to person. The decisive factor is how early and how specifically supportive measures are implemented.<\/p>


    What factors influence the course of Parkinson's disease?<\/strong><\/p>

    The course of Parkinson's disease is influenced by a number of factors:<\/p>

    • the onset and type of the disease,<\/li>
    • genetic and biological factors,<\/li>
    • drug therapy,<\/li>
    • Activity level and exercise behavior.

      <\/li><\/ul>

      While biological factors cannot be influenced, targeted exercise therapy in particular can make an important contribution.<\/p>

      \u00a0
      What role does movement play?<\/strong><\/p>

      Exercise is now considered a key component in the management of Parkinson's disease. Studies indicate that regular, structured exercise:<\/p>

      • mobility for longer,<\/li>
      • Everyday functions stabilized,<\/li>
      • can reduce the risk of falling.

        <\/li><\/ul>

        Not every movement is equally effective. The decisive factor is whether movement targeted, conscious and learning-oriented<\/strong> is used.<\/p>


        Why targeted training is more important than pure activity<\/strong><\/p>

        Walks or general activity are useful, but are often not enough to achieve lasting functional improvements.
        Modern therapeutic approaches - such as GIGER\u00ae MD\u00ae Therapy - are therefore based on:<\/p>

        • active, consciously controlled movement sequences,<\/li>
        • complex coordination and balance requirements,<\/li>
        • rhythmic and structured movement patterns,<\/li>
        • individually adapted training stimuli.<\/li>
        • \u00a0<\/li><\/ul>

          The aim is to specifically challenge the nervous system and stabilize functional abilities for as long as possible.
          \u00a0<\/p>

          Connection with neuroplasticity<\/p>

          Even with Parkinson's, the brain remains capable of learning. This adaptability is known as neuroplasticity.
          Therapy forms such as GIGER\u00ae MD\u00ae Therapy utilize this principle by:
          address several sensory and movement systems simultaneously,
          combine coordinative and rhythmic movements,
          actively promote motor learning.
          Neuroplasticity does not mean a cure, but better utilization of existing neuronal resources.<\/p>

          \u00a0
          Where are the limits?<\/strong><\/p>

          As important as targeted exercise therapy is, it is no substitute for medical treatment.Parkinson's remains a progressive neurological disease.
          The goal is therefore not healing, but:<\/p>

          • slow down functional degradation,<\/li>
          • quality of life for as long as possible,<\/li>
          • to promote safety and independence in everyday life.<\/li><\/ul>

            Therapy approaches such as GIGER\u00ae MD\u00ae therapy should be seen as a supplementary, supportive measure.<\/p>

            \u00a0
            Conclusion<\/strong><\/p>

            Parkinson's cannot be cured. Nevertheless, those affected can actively contribute to positively influencing the functional course of the disease.
            Regular, targeted exercise - especially in structured forms of therapy such as GIGER\u00ae MD\u00ae Therapy - can help to maintain mobility, coordination and everyday safety for longer.
            \u00a0<\/p>


            Author: Combo AG, manufacturer and distributor of GIGER\u00ae MD\u00ae Therapy
            <\/strong>Medical note: This article is for information purposes only and does not replace medical advice or treatment.Last update: 2026<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

            Kann man den Verlauf der Erkrankung verlangsamen? Einleitung Eine der h\u00e4ufigsten Fragen von Menschen mit Parkinson und ihren Angeh\u00f6rigen lautet:\u2028\u201eKann man den Verlauf der Erkrankung verlangsamen?\u201c Parkinson ist derzeit nicht heilbar. Dennoch zeigen medizinische Erkenntnisse, dass bestimmte therapeutische Ans\u00e4tze den funktionellen Verlauf der Erkrankung positiv beeinflussen k\u00f6nnen. Dabei spielen gezielte Bewegung, motorisches Lernen und individuell […]<\/p>\n","protected":false},"author":1,"featured_media":66354,"comment_status":"closed","ping_status":"open","sticky":false,"template":"elementor_header_footer","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[7353,7352],"tags":[],"class_list":["post-66350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-parkinson"],"_links":{"self":[{"href":"https:\/\/www.parkinson-hotline.com\/en\/wp-json\/wp\/v2\/posts\/66350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.parkinson-hotline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.parkinson-hotline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/en\/wp-json\/wp\/v2\/comments?post=66350"}],"version-history":[{"count":17,"href":"https:\/\/www.parkinson-hotline.com\/en\/wp-json\/wp\/v2\/posts\/66350\/revisions"}],"predecessor-version":[{"id":66685,"href":"https:\/\/www.parkinson-hotline.com\/en\/wp-json\/wp\/v2\/posts\/66350\/revisions\/66685"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/en\/wp-json\/wp\/v2\/media\/66354"}],"wp:attachment":[{"href":"https:\/\/www.parkinson-hotline.com\/en\/wp-json\/wp\/v2\/media?parent=66350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/en\/wp-json\/wp\/v2\/categories?post=66350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/en\/wp-json\/wp\/v2\/tags?post=66350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}